Therapy-induced APOBEC3A drives evolution of resistance to targeted therapies in non-small cell lung cancer
Targeted Therapy
DOI:
10.5281/zenodo.7945752
Publication Date:
2024-05-17
AUTHORS (4)
ABSTRACT
Mutation calls from cell line samples. (Supplementary Table 6)
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES ()
CITATIONS ()
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....